Skip to main content

Table 3 The multivariate regression analysis of prognostic factors of 6-month ΔHt SDS

From: Polyethylene glycol recombinant human growth hormone in Chinese prepubertal slow-growing short children: doses reported in a multicenter real-world study

Variable

β (95% CI)

P

Baseline BA/ Baseline CA

-0.285 (-0.478, -0.092)

0.0039

Baseline Ht SDS

-0.0045 (-0.038, 0.028)

0.7677

Dosage

2.173 (1.250, 3.095)

 < 0.0001

Baseline IGF-1 SDS

-0.031 (-0.060, -0.002)

0.0378

Baseline BMI SDS

0.021 (-0.001, 0.043)

0.0655

Female

0.005 (-0.044, 0.055)

0.8281

GH peak

-0.008 (-0.018, 0.002)

0.1230

  1. Ht height, SDS standard deviation score, CI confidence interval, BA bone age, CA chronological age, IGF-1 insulin growth factor-1, BMI body mass index, GH growth hormone